Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.
Journal of Clinical Oncology.
Times cited: 385
Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec): Bone marrow histopathology and correlation with genetic status.
American Journal of Clinical Pathology.
Times cited: 31
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
New England Journal of Medicine.
Times cited: 1717